3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
32
Neoplasms
26
Depression
21
Fatigue
20
Prostatic Neoplasms
13
Lymphoma, Follicular
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Multiple Myeloma
11
Lymphoma, Large B-Cell, Diffuse
10
Lung Neoplasms
10
Colorectal Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Pain
9
Lymphoma, Non-Hodgkin
9
Lymphoma, Mantle-Cell
9
Lymphoma, Large-Cell, Immunoblastic
9
Lymphoma, B-Cell, Marginal Zone
9
Leukemia, Myeloid, Chronic-Phase
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Hodgkin Disease
9
Burkitt Lymphoma
9
Anxiety Disorders
9
Vomiting
7
Nausea
7
Leukemia, Myeloid, Acute
7
Leukemia, Myeloid, Accelerated Phase
7
Leukemia, Hairy Cell
7
Head and Neck Neoplasms
7
Carcinoma, Ovarian Epithelial
7
Blast Crisis
7
Interventions
Doxorubicin
15
Zidovudine
12
Vincristine
11
Bleomycin
10
Interferon alpha-2
6
Cyclophosphamide
5
tecogalan
4
sargramostim
4
Methotrexate
4
Liposomes
4
Leucovorin
4
Filgrastim
4
Etoposide
4
Dexamethasone
4
Cytarabine
4
Fluorouracil
3
interferon alfa-n1
2
Valganciclovir
2
Tumor Necrosis Factor-alpha
2
Thalidomide
2
Rituximab
2
Ritonavir
2
Nivolumab
2
Mitoxantrone
2
Isotretinoin
2
Interleukin-2
2
Electrocoagulation
2
Didanosine
2
Allopurinol
2
ziconotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Acquired Immunodeficiency Syndrome
×
Therapeutics
×
Clear all
NCT02615860
2022-11-08
TECAIN
University Hospital, Essen
Phase NA
Completed
560 enrolled